| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Chief Med. &Dev. Officer | Chief Medical &Devt. Officer | Chief Medical Officer
2 companies
Rajangam Kanya is a President &Chief Med. &Dev. Officer at SNTI, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 3 sales.
Our model assigns Rajangam Kanya a strong insider score of 77/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +72.1%.